- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Maximum tolerated dose
Total 21264 results
-
Noxopharm LimitedTerminatedMetastatic Soft-tissue SarcomaUnited States
-
Noxopharm LimitedTerminatedMetastatic Castration-resistant Prostate Cancer and Other Solid TumorsUnited States
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia
-
Calgent Biotechnology Co., LtdCompletedResistant or Refractory Solid TumorsUnited States, Taiwan
-
Millennium Pharmaceuticals, Inc.CompletedDigestive System DiseaseUnited States
-
Grupo Espanol de Investigacion en SarcomasActive, not recruitingDrug Use | GIST | Drug Toxicity | Metastatic Adult Soft Tissue Sarcoma | Maximum Tolerated DoseSpain
-
CHA UniversityAjou University School of MedicineCompletedNeoplasms, Germ Cell and Embryonal | Glioblastoma | Recurrent Glioblastoma | Adult Gliosarcoma | Neoplasms, BrainKorea, Republic of
-
University of Colorado, DenverCompletedPancreatic CancerUnited States
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLCTerminatedMetastatic Non-small-cell lunG CancerUnited Kingdom
-
Molecular Templates, Inc.TerminatedLeukemia, Lymphocytic, Chronic, B-Cell | Diffuse Large B Cell Lymphoma | Blood Cancer | Hematological Malignancy | Small Lymphocytic Leukemia | Non-Hodgkin's B-cell LymphomaUnited States, Canada, Georgia, Belarus, Spain, Israel, Moldova, Republic of, Poland, Serbia, Ukraine
-
CytoDyn, Inc.Amarex Clinical ResearchActive, not recruitingTriple Negative Breast NeoplasmsUnited States
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States, Australia
-
ImmunityBio, Inc.CompletedMalignant Solid TumourUnited States
-
ImmunityBio, Inc.Completed
-
M.D. Anderson Cancer CenterSunesis PharmaceuticalsCompleted
-
Azienda Ospedaliera Universitaria Mater Domini,...Associazione Italiana per la Ricerca sul CancroCompletedAdvanced Solid Tumor | Hepatocarcinoma | Multiple Myeloma, RefractoryItaly
-
University of Michigan Rogel Cancer CenterCompletedLymphoma, Non-Hodgkin | Hodgkin's LymphomaUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.Completed
-
National Cancer Institute (NCI)CompletedSubcutaneous Panniculitis-Like T-Cell Lymphoma | T-Cell Peripheral Lymphoma | Gamma Delta Hepatosplenic T-Cell Lymphoma | NK T-Cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedEpithelial Tumors, Malignant | Epithelial Neoplasms, Malignant | Malignant Mesenchymal TumorUnited States
-
AbbVieGenentech, Inc.Completed
-
ABL Bio, Inc.National OncoVentureCompleted
-
Onconova Therapeutics, Inc.TerminatedNeoplasms | Advanced Solid TumorUnited States
-
BayerTerminatedSmall Cell Lung CarcinomaUnited States, Korea, Republic of, France
-
McMaster UniversityMediPharm Labs CorpWithdrawnGeneralized Anxiety Disorder | Social Anxiety Disorder | Panic Disorder | AgoraphobiaCanada
-
National Cancer Institute (NCI)CompletedBreast Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Tumors (Others)United States
-
National Cancer Institute (NCI)TerminatedRenal Cell Carcinoma | Renal Cell Cancer | Hereditary LeiomyomatosisUnited States
-
Novartis PharmaceuticalsCompletedHepatocellular CarcinomaUnited States, Taiwan, Germany, Italy, Hong Kong, Canada, Japan, Spain
-
Novartis PharmaceuticalsCompletedMetastatic Colorectal Cancer | Gastric Cancer | Advanced Solid Tumors | Metastatic Breast Cancer | Gastroesophageal Junction Cancer | Recurrent Glioblastoma Multiforme | Advanced Pancreatic Adenocarcinoma | Safety | Triple Negative Metastatic Breast Cancer | Dose Escalation | Preliminary Efficacy | Hormone Receptor...Canada, United Kingdom, Spain, Germany, Italy, Belgium, Australia, United States
-
Novartis PharmaceuticalsIncyte CorporationTerminatedMyelofibrosisSpain, United Kingdom, Australia, Israel, Germany, Italy, Singapore, Austria, France
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaGermany, Spain, Singapore, United States, Australia
-
National Health Research Institutes, TaiwanTerminatedHead and Neck Cancer | NSCLCTaiwan
-
Novartis PharmaceuticalsCompletedBreast Cancer | Hematologic NeoplasmsNetherlands, Switzerland, United Kingdom, United States
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsUnited States
-
Novartis PharmaceuticalsTerminated
-
Baylor College of MedicineChildren's Hospital Medical Center, CincinnatiCompletedSickle Cell DiseaseUnited States
-
Jonsson Comprehensive Cancer CenterPfizerCompleted
-
SunovionCompletedSchizophreniaUnited States
-
Merck KGaA, Darmstadt, GermanyCompletedChronic Lymphocytic Leukemia | Advanced Solid TumorsBelgium, Netherlands, Denmark
-
Novartis PharmaceuticalsCompletedBone Marrow Diseases | Hematologic Diseases | Blood Coagulation Disorders | Hemorrhagic Disorders | Primary Myelofibrosis | Myeloproliferative Disorders | Polycythemia Vera | Thrombocytosis | Essential Thrombocythemia | Blood Platelet DisordersUnited Kingdom, Belgium, Canada, France, Australia, Netherlands, Spain, Denmark, Ireland, Italy, Germany
-
CelgeneMultiple Myeloma Research ConsortiumCompleted
-
AbbVieTerminatedColorectal CancerUnited States
-
Astex Pharmaceuticals, Inc.Completed
-
Acrotech Biopharma Inc.National Cancer Institute (NCI)CompletedSarcoma | Lymphoma | Leukemia | Neuroblastoma | Brain Tumors | Wilms TumorUnited States
-
Acrotech Biopharma Inc.CompletedPeripheral T-cell LymphomaUnited States
-
CelgeneTerminatedCarcinoma, Small CellUnited States, Canada
-
CelgeneTerminatedNeoplasm MetastasisUnited States, Australia
-
CelgeneCompletedAnemia, Sickle CellUnited States